SEC Form 4 · accession 0001062993-18-004211
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Sidransky
Director
Period of report
Jul 16, 2013
Accepted (ET)
Oct 25, 2018 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $9.00 | Jul 16, 2013 | A | 20,834 | A | — | Jul 16, 2023 | Common Stock | 20,834 | 20,834 | D |
Explanation of responses
- F1Represents post-reverse stock split share amounts.
- F2These options were awarded under the Issuer's 2012 Equity Incentive Plan to purchase shares of common stock of the Issuer and vested over a period of 5 years, with 20% of the award vesting at the end of each successive anniversary of the award date.